CapecitabineadebrelimabImmunotherapyCholangiocarcinomaNCT06607276CCA
…arries a high risk of recurrence even after curative resection. Capecitabine is standard adjuvant therapy, but recurrence rates remain signi…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 390 of 876dexamethasonemethylprednisolonehydrocortisoneHCPostoperative delirium (POD)Japan Registry of Clinical TrialsNagoya University Clinical Research Review Board
…easing hospital stays, costs and mortality. Corticoids, such as dexamethasone and methylprednisolone, have been reported to reduce POD. Howev…
elexacaftorivacaftortezacaftorcystic fibrosisCFCFTRMonash Health Human Research Ethics Committee
…ts and children 4 months to 5 years of age who are eligible for elexacaftor/tezacaftor/ivacaftor (ETI) or ivacaftor (IVA) meet the inclusio…
BrolucizumabGuangdong Provincial People’s Hospitaldiabetic macular edema
…used significant vision loss and substantial treatment burdens. Brolucizumab is a new-generation anti-VEGF agent with better anatomical effi…
BedaquilineBDQPubMedCochrane LibraryWeb of ScienceAfrican Journals OnlineEmbaseWHODR-TBTB+2 more
… drug-resistant TB (DR-TB) and its strong association with HIV. Bedaquiline (BDQ), approved by the WHO in 2013, offers a promising treatmen…
renin-angiotensin system inhibitorsbeta-blockersstatinsantiplateletstype 2 diabetes mellituschronic kidney diseaseheart failureCKDHFT2D+1 more
…is. In CKD+HF, CKD+T2D and HF+T2D groups, prescription rates of renin-angiotensin system inhibitors (71%, 64.1% and 74.4%), beta-blockers (53.1%,36.2% and 55.1%), …
atomoxetineNoradrenalineMedicines and Healthcare products Regulatory AgencyProgressive supranuclear palsyREC
…ood and potential baseline predictors of individual response to atomoxetine computed from imaging, genetic and cognitive measures at baseli…
KetamineS-ketaminesevere acute brain injuryneurointensive care unitaneurysmal subarachnoid haemorrhageneurosurgical step-down unitDanish Medicines Agencyspontaneous intracerebral haemorrhagetraumatic brain injuryCortical spreading depolarisation+1 more
…upregulation of cerebral metabolism in vulnerable brain tissue. Ketamine appears to inhibit SDs both in vitro and in patient series of s…
Artemether/lumefantrineArtemisininquinineACAsmalaria
…ies on the mainland (30.9%) compared with Bioko Island (25.6%). Artemether/lumefantrine, the first-line treatment for malaria in EG, showed 25.7% were …
L-tyrosinecaffeineNootropics
…riods of high military specific stress. Currently, caffeine and L-tyrosine are the leading nootropic supplement candidates within the mili…
cannabiscannabis-relatedNorwegian Patient RegistryCANN2021Education, Crime, Income and Population Registry
…ination of temporal associations between various types of early cannabis involvement and putative risk and protective factors, and subse…